GR1001291B - Πεπτιδια και αντισωματα αναστελλοντα την ζευξιν της integrin μετα συντασσομενης ομαδος. - Google Patents

Πεπτιδια και αντισωματα αναστελλοντα την ζευξιν της integrin μετα συντασσομενης ομαδος.

Info

Publication number
GR1001291B
GR1001291B GR890100632A GR890100632A GR1001291B GR 1001291 B GR1001291 B GR 1001291B GR 890100632 A GR890100632 A GR 890100632A GR 890100632 A GR890100632 A GR 890100632A GR 1001291 B GR1001291 B GR 1001291B
Authority
GR
Greece
Prior art keywords
antibodies
ligand binding
peptides
integrin
polypeptides
Prior art date
Application number
GR890100632A
Other languages
English (en)
Other versions
GR890100632A (en
Inventor
Souza Stanley E D
Mark H Ginsberg
Edward F Plow
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/252,674 external-priority patent/US5149780A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of GR890100632A publication Critical patent/GR890100632A/el
Publication of GR1001291B publication Critical patent/GR1001291B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Περγράφονται πολυπεπτίδια προερχόμενα εκ της περιοχής δεσμεύσεως (χημικός τύπος) (RGD) μιας β-υπο-ομάδος Integrin ως και η χρήσις αυτών εις την τροποποίησιν της ζεύξεως της 5 Integrin μετά στοιχείου συνδέσεως. Αναφέρονται επίσης αντιπεπτιδικά αντισώματα, υβριδώματα εκκρίνοντα τα τοιαύτα αντισώματα, ως και μέθοδοι παραγωγής και χρήσεως των τοιούτων αντισωμάτων, ως και μόρια DNA εξ ανασυνθέσεως ορίζοντα δομικόν γονίδιον το οποίον κωδικοποιεί τα πολυπεπτίδια, ως εμπίπτοντα εις το αντικείμενον της παρούσης εφευρέσεως. ω
GR890100632A 1988-10-03 1989-10-03 Πεπτιδια και αντισωματα αναστελλοντα την ζευξιν της integrin μετα συντασσομενης ομαδος. GR1001291B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/252,674 US5149780A (en) 1988-10-03 1988-10-03 Peptides and antibodies that inhibit integrin-ligand binding
US07/415,025 US5204445A (en) 1988-10-03 1989-10-02 Peptides and antibodies that inhibit integrin-ligand binding

Publications (2)

Publication Number Publication Date
GR890100632A GR890100632A (en) 1990-11-29
GR1001291B true GR1001291B (el) 1993-07-30

Family

ID=26942544

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100632A GR1001291B (el) 1988-10-03 1989-10-03 Πεπτιδια και αντισωματα αναστελλοντα την ζευξιν της integrin μετα συντασσομενης ομαδος.

Country Status (10)

Country Link
US (1) US5204445A (el)
EP (1) EP0436660B1 (el)
AT (1) ATE136908T1 (el)
AU (1) AU4427389A (el)
CA (1) CA2000048A1 (el)
DE (1) DE68926303T2 (el)
ES (1) ES2024728A6 (el)
GR (1) GR1001291B (el)
PT (1) PT91888A (el)
WO (1) WO1990003983A1 (el)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432249B1 (en) * 1989-06-02 1996-09-25 The Johns Hopkins University School Of Medicine Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
GB8914020D0 (en) † 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
WO1992003473A1 (en) * 1990-08-27 1992-03-05 Cetus Corporation Cd18 peptide medicaments for the treatment of disease
JPH06507641A (ja) * 1991-05-03 1994-09-01 ザ ロックフェラー ユニバーシティ 白血球ｃｒ３に対する内皮細胞リガンド認識抗体
EP0593572B1 (en) * 1991-07-01 1998-06-17 The Blood Center Of Southeastern Wisconsin PEN POLYMORPHISM OF HUMAN PLATELET MEMBRANE GLYCOPROTEIN IIIa AND DIAGNOSTIC AND THERAPEUTIC APPLICATION THEREOF
US5962643A (en) * 1991-07-11 1999-10-05 The Regents Of The University Of California Integrin β subunit and uses thereof
CA2109398A1 (en) * 1992-10-30 1994-05-01 Alejandro A. Aruffo Extracellular matrix receptor ligands that modulate leukocyte function
EP0762886A4 (en) * 1994-04-19 1999-03-31 Univ Kansas ICAM-1 / LFA-1 SHORT CHAIN PEPTIDES AND METHODS FOR USE THEREOF
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US6465253B1 (en) * 1994-09-08 2002-10-15 Genvec, Inc. Vectors and methods for gene transfer to cells
US5559099A (en) * 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
AU698317B2 (en) 1995-02-25 1998-10-29 Cancer Research Technology Limited Transgenic animals as model of psoriasis
ES2333425T5 (es) * 1995-06-15 2012-08-28 Crucell Holland B.V. Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica
US6783980B2 (en) * 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US5817750A (en) * 1995-08-28 1998-10-06 La Jolla Cancer Research Foundation Structural mimics of RGD-binding sites
PL327679A1 (en) 1996-01-10 1998-12-21 Nycomed Imaging As Contast medium
GB9600427D0 (en) * 1996-01-10 1996-03-13 Nycomed Imaging As Contrast media
US6087332A (en) * 1997-12-23 2000-07-11 Galler; Lawrence Isaac Streptokinase derivatives with high affinity for activated platelets and methods of their production and use in thrombolytic therapy
US20040043489A1 (en) * 1998-07-08 2004-03-04 Menzo Havenga Gene delivery vectors provided with a tissue tropism for dendritic cells and methods of use
US20030017138A1 (en) * 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6929946B1 (en) * 1998-11-20 2005-08-16 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
US20050232900A1 (en) * 1999-05-18 2005-10-20 Crucell Holland B.V. Serotype of adenovirus and uses thereof
US6492169B1 (en) * 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
AU6090200A (en) * 1999-07-15 2001-02-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Peptides and their utility in modulation of behavior of cells expressing alpha3beta1 integrins
US7129052B1 (en) * 2000-07-12 2006-10-31 The United States Of America As Represented By The Department Of Health And Human Services Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
EP1157999A1 (en) * 2000-05-24 2001-11-28 Introgene B.V. Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
US20040033605A1 (en) * 2000-09-20 2004-02-19 Menzo Havenga Gene delivery vectors provided with a tissue tropism for dendritic cells
DE60138403D1 (de) * 2000-09-26 2009-05-28 Crucell Holland Bv Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
MXPA03007878A (es) * 2001-03-02 2004-07-08 Medimmune Inc Metodos de prevencion o tratamiento de alteraciones inflamatorias o autoinmunes mediante la administracion de los antagonistas alfav, beta3 de integrina.
AU2003210661A1 (en) * 2002-01-24 2003-09-02 Novartis Ag Fiber shaft modifications for efficient targeting
CA2478239A1 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
WO2003075741A2 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
AU2003226065B2 (en) * 2002-04-12 2009-02-26 Ludwig Institute For Cancer Research, Ltd Recombinant anti-interleukin-9 antibodies
SI1497438T1 (sl) * 2002-04-25 2010-03-31 Crucell Holland Bv Sredstva in postopki za pripravo adenovirusnih vektorjev
AU2004207002A1 (en) * 2003-01-30 2004-08-12 Medimmune, Inc. Uses of integrin alphavbeta3 antagonists
KR20120035234A (ko) * 2003-04-11 2012-04-13 메디뮨 엘엘씨 재조합 ｉｌ?９ 항체 및 그의 용도
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
EP2422811A2 (en) 2004-10-27 2012-02-29 MedImmune, LLC Modulation of antibody specificity by tailoring the affinity to cognate antigens
EP2043603A4 (en) 2006-07-11 2010-10-27 Arubor Corp PREVENTION AND THERAPY OF RHINOSINUSITIS WITH PROINFLAMMATORY CYTOKINHERMERS
HUE048024T2 (hu) 2006-08-10 2020-05-28 Roy C Levitt Anakinra bronchiolitis obliterans szindróma kezelésében való alkalmazásra
EP4219560A3 (en) * 2010-02-18 2023-08-23 The Regents of The University of California Integrin alpha v beta 8 neutralizing antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006592A1 (en) * 1987-02-26 1988-09-07 Dana-Farber Cancer Institute, Inc. Cloning of lfa-1
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion

Also Published As

Publication number Publication date
CA2000048A1 (en) 1990-04-03
ATE136908T1 (de) 1996-05-15
US5204445A (en) 1993-04-20
EP0436660B1 (en) 1996-04-17
DE68926303T2 (de) 1996-11-21
DE68926303D1 (de) 1996-05-23
EP0436660A4 (en) 1992-02-12
WO1990003983A1 (en) 1990-04-19
EP0436660A1 (en) 1991-07-17
ES2024728A6 (es) 1992-03-01
AU4427389A (en) 1990-05-01
PT91888A (pt) 1990-04-30
GR890100632A (en) 1990-11-29

Similar Documents

Publication Publication Date Title
GR890100632A (en) Peptides and antibodies that inhibit integrin - ligand binding
IL148021A0 (en) Novel b7-4 molecules and uses therefor
NO964650D0 (no) LAG-3 protein-opplöselige polypeptidfraksjoner, fremgangsmåte for fremstilling, teraupeutisk preparat og anti-idiotype antistoff
EP1190043A4 (en) GLYCOPROTEIN VI AND ITS USES
HK129394A (en) Recombinant immunoglobulin preparations, methods for their preparation, dna sequences, expression vectors and recombinant host cells therefor
WO1999002552A3 (en) Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
EP0460076A4 (en) Genetically engineered immunoglobulins
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
AU7599500A (en) Novel gl50 molecules and uses therefor
DE59708952D1 (de) Fusionspolypeptid zur beeinflussung von wechselwirkungen zwischen proteinen
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
EP1009752A4 (en) NOVEL TANGO-77 PROTEIN FAMILY MOLECULES AND USES THEREOF
DE69930625D1 (de) Rekombinante aav-vektoren für die gentherapie von hämophilie a
DE60044193D1 (en) Tumor antigen
ATE233811T1 (de) Blutplaettchen-gpiiia p1a1 und -p1a2-epitope, ihre herstellung und verwendung
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
WO2000012544A3 (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
SG54291A1 (en) Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
HK1037209A1 (en) Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO2000018890A3 (en) Protein phosphatase molecules and uses therefor
WO2000041539A3 (en) Human beta-1,3-galactosyltransferase homolog, znssp6
WO1998057992A3 (de) Antikörper gegen flip-protein
IT1276724B1 (it) Vettore plasmidico di espressione per cellule di mammifero